Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP311901.RAr0GGWhe_uFTsYueKGrHNYnyDm6W_YvkPERG0ym6nJ04130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP311901.RAr0GGWhe_uFTsYueKGrHNYnyDm6W_YvkPERG0ym6nJ04130_assertion type Assertion NP311901.RAr0GGWhe_uFTsYueKGrHNYnyDm6W_YvkPERG0ym6nJ04130_head.
- NP311901.RAr0GGWhe_uFTsYueKGrHNYnyDm6W_YvkPERG0ym6nJ04130_assertion wasGeneratedBy ECO_0000203 NP311901.RAr0GGWhe_uFTsYueKGrHNYnyDm6W_YvkPERG0ym6nJ04130_provenance.
- NP311901.RAr0GGWhe_uFTsYueKGrHNYnyDm6W_YvkPERG0ym6nJ04130_assertion wasDerivedFrom befree-20150227 NP311901.RAr0GGWhe_uFTsYueKGrHNYnyDm6W_YvkPERG0ym6nJ04130_provenance.
- NP311901.RAr0GGWhe_uFTsYueKGrHNYnyDm6W_YvkPERG0ym6nJ04130_assertion SIO_000772 21661378 NP311901.RAr0GGWhe_uFTsYueKGrHNYnyDm6W_YvkPERG0ym6nJ04130_provenance.
- NP311901.RAr0GGWhe_uFTsYueKGrHNYnyDm6W_YvkPERG0ym6nJ04130_assertion evidence source_evidence_literature NP311901.RAr0GGWhe_uFTsYueKGrHNYnyDm6W_YvkPERG0ym6nJ04130_provenance.
- NP311901.RAr0GGWhe_uFTsYueKGrHNYnyDm6W_YvkPERG0ym6nJ04130_assertion description "[At present, no markers are available for an early diagnosis of breast cancer For surveillance of patients with diagnosed breast cancer the most widely used serum markers are CA 15-3 and CEA which, in combination with other clinical parameters, could have clinical significance.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP311901.RAr0GGWhe_uFTsYueKGrHNYnyDm6W_YvkPERG0ym6nJ04130_provenance.